Our life sciences patent attorneys are litigators and scientists with deep industry, technology, and legal expertise.
O’Melveny is home to some of the nation’s most prominent Hatch Waxman practitioners.led by LMG Life Science Hatch Waxman (Brand) Litigator of the Year and one of the Top 250 Women in Intellectual Property IP managementOur team, which includes a physician and several Ph.D.s, is recognized for our legal ability, diversity, and customer service.
We are also a world leader in biologics and biosimilars. We were one of the first firms to advise clients on the Biologics Price Competition and Innovation Act, and the largest international biotechnology trade organization has amicus briefs in first impression cases related to the Act. O’Melveny was asked to submit the following.
Similarly, we represent manufacturers of medical devices, diagnostics, and other medical technologies in the enforcement and defense of their patent rights. Led by a first trial attorney with advanced degrees in physiology and biophysics, our team guides clients through U.S. District Court, U.S. International Trade Commission, U.S. Patent and Trademark Office litigation, and private arbitration.
We have also played a leading role in some of the life sciences industry’s most significant trade secret matters, including helping negotiate a $22.5 million settlement against Agilent Technologies in a trade secret matter involving DNA printing.
